SI9300309A - Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo - Google Patents

Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo Download PDF

Info

Publication number
SI9300309A
SI9300309A SI9300309A SI9300309A SI9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A
Authority
SI
Slovenia
Prior art keywords
formula
piperazine
wavy line
nitrogen
group
Prior art date
Application number
SI9300309A
Other languages
English (en)
Slovenian (sl)
Inventor
Zoltan Tuba
Sandor Maho
Aniko Gere
Pal Vittay
Bela Kiss
Eva Palosi
Laszlo Szporny
Csaba Szantay
Ferenc Soti
Roj Kardos Zsuzsa Balogh
Maria Incze
Gabor Balogh
Maria Gazdag
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SI9300309A publication Critical patent/SI9300309A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
SI9300309A 1992-06-09 1993-06-09 Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo SI9300309A (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9201911A HU209678B (en) 1992-06-09 1992-06-09 Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SI9300309A true SI9300309A (sl) 1993-12-31

Family

ID=10982021

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300309A SI9300309A (sl) 1992-06-09 1993-06-09 Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo

Country Status (18)

Country Link
US (1) US5510345A (ko)
EP (1) EP0644885A1 (ko)
JP (1) JPH07507793A (ko)
KR (1) KR950701924A (ko)
AU (1) AU4352493A (ko)
CA (1) CA2136547A1 (ko)
CZ (1) CZ307994A3 (ko)
EE (1) EE9400070A (ko)
FI (1) FI945780A0 (ko)
GR (1) GR1001597B (ko)
HR (1) HRP930957A2 (ko)
HU (1) HU209678B (ko)
IL (1) IL105942A0 (ko)
LT (1) LT3118B (ko)
NZ (1) NZ253308A (ko)
SI (1) SI9300309A (ko)
WO (1) WO1993025550A1 (ko)
ZA (1) ZA934037B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1799664A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
BRPI0515505A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
EP1799668A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580787A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7820654B2 (en) * 2004-09-23 2010-10-26 Dr. Reddy's Laboratories Ltd. Pyrimidine compounds, process for their preparation and compositions containing them
US8541457B2 (en) 2005-06-03 2013-09-24 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
EP2276750A2 (en) * 2008-03-27 2011-01-26 Auckland Uniservices Limited Substituted pyrimidines and triazines and their use in cancer therapy
CN101928286A (zh) * 2009-06-18 2010-12-29 谢开智 长春胺衍生物及制备方法
ES2753386T3 (es) 2013-03-13 2020-04-08 Forma Therapeutics Inc Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer
WO2017210545A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
SG11201905893WA (en) 2017-01-23 2019-08-27 Cadent Therapeutics Inc Potassium channel modulators
MX2021004647A (es) 2018-10-22 2021-08-16 Novartis Ag Formas cristalinas de moduladores de los canales de potasio.
CN113382633A (zh) 2018-10-29 2021-09-10 福马治疗股份有限公司 (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2176516B1 (ko) * 1972-03-22 1975-03-14 Synthelabo
HU171663B (hu) * 1975-09-01 1978-02-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
WO1987001706A2 (en) 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
AU7580187A (en) 1986-06-23 1988-01-12 Upjohn Company, The Androstane-type and cortical aminoesters
KR890700581A (ko) 1987-04-03 1989-04-25 로버어트 에이 아미테이지 아미노 -9,10-세코스테로이드
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
FR2644788B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644787B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644789B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
AU642711B2 (en) 1990-01-26 1993-10-28 Upjohn Company, The 5-oxygenated-2,4,6-triaminopyrimidines

Also Published As

Publication number Publication date
US5510345A (en) 1996-04-23
ZA934037B (en) 1994-01-06
WO1993025550A1 (en) 1993-12-23
AU4352493A (en) 1994-01-04
HU9201911D0 (en) 1992-09-28
NZ253308A (en) 1995-11-27
CZ307994A3 (en) 1995-07-12
CA2136547A1 (en) 1993-12-23
LT3118B (en) 1994-12-27
GR1001597B (el) 1994-06-30
KR950701924A (ko) 1995-05-17
JPH07507793A (ja) 1995-08-31
HRP930957A2 (en) 1995-02-28
FI945780A (fi) 1994-12-08
LTIP599A (en) 1994-07-15
EP0644885A1 (en) 1995-03-29
HU209678B (en) 1994-10-28
IL105942A0 (en) 1993-10-20
FI945780A0 (fi) 1994-12-08
EE9400070A (et) 1995-12-15
HUT64540A (en) 1994-01-28

Similar Documents

Publication Publication Date Title
SI9300309A (sl) Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo
US4996318A (en) Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
EP3584239A1 (en) O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereof
EP2872524B1 (de) 3-substituierte estra-1,3,5 (10),16-tetraen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
PL175347B1 (pl) Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie
US5547949A (en) Steroids with pregnane skeleton, pharmaceutical compositions containing them
HU212133B (en) Therapeutic agents
WO1987007895A1 (en) Androstane-type and cortical aminoesters
US4256886A (en) Process for the preparation of oxadiazolopyrimidine derivatives
DE2804519C2 (ko)
DE3150486A1 (de) Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
US5099019A (en) Amines useful in producing pharmaceutically active CNS compounds
US4150132A (en) Oxadiazolopyrimidine derivatives
JPH03246282A (ja) トリアゾリルヒドラジド誘導体、その製造方法、およびその誘導体を活性成分とする抗狭心症または胃潰瘍防止用製剤組成物とその製造方法
DE60002692T2 (de) Leberspezifische gallensaeurederivate des antiglukokorticoids ru486
EP0665238B1 (en) Corticoid derivatives and pharmaceutical and cosmetic compositions
NO771697L (no) Fremgangsm}te for fremstilling av fysiologisk aktive isotiourinstoffer
DK175347B1 (da) Aminosubstitueret steroid, Delta9(11)-steroid og amin samt farmaceutisk acceptable salte, hydrater og solvater deraf
LT3071B (en) Novel steroids with pregnane skeleton,pharmaceutical compositions containing them and process for preparing thereof
USRE35053E (en) Amines useful in producing pharmaceutically active CNS compounds
US4656172A (en) 1-[5-(3,4,5-Trimethoxy phenyl)-2,4-pentadienoyl]-4-(substituted carbonylmethyl)-piperazines having vasodilating activity
HU212310B (hu) Eljárás biológiailag aktív, új androsztán-származékok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására
NZ217478A (en) Steroids with 20- and 21-amino substitution
HU212419B (en) Process for producing biologically active amino-steroids with androstane-and estrane-structure and pharmaceutical compositions containing the same